?? Exciting News from CONDUCTink! ?? We are thrilled to announce that Louis S. Paone & Peter Galie are heading to San Francisco for the JP Morgan Healthcare Conference! ?? Our mission is to revolutionize preclinical drug development through innovative microphysiological tissue models, empowering drug developers with unmatched flexibility and reliability to bring life-changing medicines to patients faster. We’re eager to connect with pre-seed and seed-stage investors who share our vision of disrupting the preclinical landscape and transforming patient care. If you’re attending JPM and would like to learn more about CONDUCTink, let’s connect! Together, we can make a significant impact on healthcare innovation. #JPM2025 #biotech #healthcareinnovation #drugdevelopment
CONDUCTink
生物技术研究
Mullica Hill，New Jersey 195 位关注者
Rebuilding the circuitry of the central nervous system.
关于我们
CONDUCTink is a biotechnology company that engineers materials to both model and regenerate the central nervous system. Our mission is to support both researchers and patients by creating platforms that both accelerate drug development and produce regenerative strategies to repair injured tissue. Our unique workflows in material synthesis interface both mechanical and biochemical stimuli to drive organized and spatially controlled human biology.
- 网站
-
https://www.conduct-ink.com/
CONDUCTink的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Mullica Hill，New Jersey
- 类型
- 私人持股
- 创立
- 2023
- 领域
- Tissue Engineering、Drug Discovery和Toxicology
地点
-
主要
获取路线
107 Gilbreth Pkwy
US，New Jersey，Mullica Hill，08062
CONDUCTink员工
动态
-
Our team will be attending the I-Corps Hub Northeast Region annual meeting at Princeton University to present our latest work on combinatorial approaches to biomaterials and therapeutic delivery for CNS injury & disease! Excited to meet and connect with industry stakeholders along with other academic startups in the NJ biotech ecosystem.
-
-
We are excited to announce our recent funding award from the New Jersey Economic Development Authority (NJEDA) for the development of our Alzheimer's Disease drug discovery model! Follow us on our journey to providing better alternatives to animal-based preclinical drug development platforms.
-
Check out our revamped website to learn how passionate we are about restoring neurological health to patients globally! https://lnkd.in/ej_fbW3g ?
-
CONDUCTink转发了
Peter Galie, Ph.D., an associate professor in the biomedical department, and Louis S. Paone, Ph.D. student, are paving the way for groundbreaking advancements in Alzheimer's research with their company, CONDUCTink. Leveraging their expertise and a novel 3D-printable biomaterial developed at Rowan University's lab, they're revolutionizing preclinical therapeutic discovery for Alzheimer's disease. Their perfusable in-vitro models promise a more effective, ethical, and accurate alternative to animal testing, bringing hope for improved treatments and ultimately, better lives for patients. Supported by the @I-Corps Hub Northeast Region, Paone and Galie are turning their passion for innovation into real-world impact. Let's support their journey to transform healthcare! https://lnkd.in/eaqKezcW #CONDUCTink #BiotechInnovation #AlzheimersResearch Rowan University
-
-
We are grateful to Henry M. Rowan College of Engineering for the write-up! Go check it out below!